DADE ACTIN FSL ACTIVATED PTT REAGENT 10445714

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2018-01-10 for DADE ACTIN FSL ACTIVATED PTT REAGENT 10445714 manufactured by Siemens Healthcare Diagnostics Products Gmbh.

Event Text Entries

[97737956] The operator indicated that the cause of the event was potentially due to improper mixing of sample tubes. The operator discussed proper specimen handling and mixing with the other technicians in the lab and the operator indicated that they have not experienced any other issues. The operator also ran a precision test on the sysmex ca-1500 system and the precision test recovered within specifications. On 19- sep-2017, siemens healthcare diagnostics (siemens) performed preventative maintenance (pm) on the affected system. A siemens headquarters support center (hsc) specialist further analyzed the event to determine the cause of the discordant, falsely elevated activated partial thromboplastin time (aptt) results on the sysmex ca-1500 system. The hsc specialist determined that quality controls (qcs) were within expected ranges prior to and after running the patient samples. Since the precision data recovered within specifications, there is no indication of a system issue. The hsc specialist determined that variability in aptt results was only observed for samples that were elevated, above the therapeutic range, for monitoring of unfractionated (uf) heparin therapy. Since all results obtained on the affected sample were highly elevated, a change in interpretation of results is not expected. Due to the fact that the repeat result was consistent after re-centrifugation, the discordant result was potentially not due to a pre-analytical sample handling issue. Elevated aptt results of >90 seconds are associated with patients on uf heparin therapy. Proper monitoring of this therapy requires that the sample is collected at the correct time, upon uf heparin therapy administration, to reflect the patient's coagulation status. Samples containing uf heparin should be run within 2 hours of collection and failure to run the patient sample within 2 hours, may lead to neutralization of uf heparin. If the sample was reanalyzed 2 hours after collection, this potentially resulted in the lower aptt recovery. The cause of the event is unknown. The system and reagent are performing according to specifications. No further evaluation of this reagent or system is required.
Patient Sequence No: 1, Text Type: N, H10


[97737957] Discordant, falsely elevated activated partial thromboplastin time (aptt) results were obtained on a patient sample on the sysmex ca-1500 system. These results were not provided to the physician(s). The same sample was respun and rerun on the same system, resulting lower. This result was reported to the physician(s), who did not question the result. On the following morning, the patient's blood was redrawn and tested for aptt and an aptt result of >139 seconds was obtained on the sample. The sample tube was checked for clots, respun and rerun on the same system. The same aptt result of >139 seconds was obtained on the sample. This result was reported to the physician, who questioned the result. The operator indicated that the result of > 139 seconds was not discordant for this patient. There are no known reports of patient intervention or adverse health consequences due to the discordant, falsely elevated aptt results.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9610806-2018-00010
MDR Report Key7180990
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2018-01-10
Date of Report2018-02-06
Date of Event2017-12-14
Date Mfgr Received2018-01-11
Date Added to Maude2018-01-10
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactCHRISTINA LAM
Manufacturer Street511 BENEDICT AVE
Manufacturer CityTARRYTOWN NY 10591
Manufacturer CountryUS
Manufacturer Postal10591
Manufacturer Phone9145243504
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Manufacturer StreetEMIL-VON-BEHRING- STR. 76
Manufacturer CityMARBURG, D-35041
Manufacturer CountryGM
Manufacturer Postal CodeD-35041
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameDADE ACTIN FSL ACTIVATED PTT REAGENT
Generic NameDADE ACTIN FSL ACTIVATED PTT REAGENT
Product CodeGGW
Date Received2018-01-10
Model NumberDADE ACTIN FSL ACTIVATED PTT REAGENT
Catalog Number10445714
Lot Number556907
Device Expiration Date2018-12-14
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Manufacturer AddressEMIL-VON-BEHRING- STR. 76 MARBURG, D-35041 GM D-35041


Patients

Patient NumberTreatmentOutcomeDate
10 2018-01-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.